Objective: The objective of this study was to evaluate whether remote ischemic preconditioning can protect kidney function in children undergoing operation for complex congenital heart disease.
and demonstrated that AKI independently almost doubled the risk of death. 1, 2 The pathogenesis of AKI is thought to lie in the initiation of a complex cascade of metabolic consequences in the tubule cells caused by renal ischemia-reperfusion injury, as well as development of an inflammatory systemic response during surgery. 3 Ischemic preconditioning refers to the intervention of inducing mild ischemia in an organ that subsequently will be subjected to prolonged ischemia. 4 Ischemic preconditioning activates endogenous protective mechanisms that ameliorate ischemia-reperfusion injury caused by the prolonged ischemic episode. Remote ischemic preconditioning (RIPC) refers to the intervention of inducing mild ischemia in a tissue distant from the organ that later on will be at risk for ischemia-reperfusion injury. 5 RIPC can be performed as short cycles of ischemia and reperfusion with an inflatable cuff on a limb. RIPC has primarily been demonstrated to protect the heart in adults and children undergoing cardiac surgery, [6] [7] [8] and ischemic preconditioning has proved beneficial in several organs (liver, lung, and brain) in human beings. [9] [10] [11] Studies of the effect of RIPC on kidney function in adults undergoing cardiovascular surgery have shown conflicting results. [12] [13] [14] [15] [16] The effect of RIPC on kidney function in children undergoing operation for congenital heart disease has not yet been investigated. The specific objective of this study was to test the effect of RIPC on kidney function in children undergoing operation for congenital heart disease. The hypothesis was that RIPC would decrease the incidence of postoperative AKI.
MATERIALS AND METHODS Study Population
Power calculation performed before the study resulted in a study population of 90 children, with 45 patients in each group. The calculation was based on the assumption that 50% of all children would have at least a 50% increase in plasma creatinine postoperatively and that RIPC would reduce this frequency to 20% (power 0.8 and a 5% significance level). The trial inclusion was stopped when 113 children had been randomly allocated.
This was a single center, stratified (0-1 month,>1 month-2 years,>2-5 years, and >5-15 years, with balanced randomization 1:1), double-blind, controlled, parallel-group study. Children aged 0 to 15 years admitted for surgery for congenital heart disease between July 2008 and December 2010 at Arhus University Hospital, Skejby, Denmark, were considered for random allocation. We excluded operations of low complexity, such as closure of septal defects and aorticopulmonary windows, establishment of Glenn shunts, subaortic membrane resection, redirection of partial anomalous pulmonary veins, valvotomies, repair of pulmonary artery stenosis, and operations without the use of extracorporeal circulation (ECC), with the purpose intent of achieving a study population with a relatively high risk of AKI.
During the study period, 288 candidates were admitted for surgery, among whom 150 met the inclusion criteria ( Figure 1 ). Two patients were included twice (>1 month between procedures with discharge in between); 1 patient was randomly allocated to the RIPC group and then the control group, and 1 patient was randomly allocated to the control group at both admissions. Before randomization, 37 patients were excluded (lack of informed consent, n ¼ 7; operations required within a few days, during which the consent for participation could not be obtained because of logistics, n ¼ 21; and unavailability of study nurse, n ¼ 9), and 113 patients were randomly allocated. After randomization, we had to exclude 8 patients: 3 patients because of postoperative need for extracorporeal membrane oxygenation (randomly allocated to the RIPC group, n ¼ 2, and control group, n ¼ 1) and 5 patients who actually turned out to fulfill exclusion criteria (4 patients because of lack of use of ECC, randomly allocated to the RIPC group, n ¼ 3, and control group, n ¼ 1; 1 patient, with expected surgery for total anomalous pulmonary veins, who only had surgery for partial anomalous pulmonary veins, randomly allocated to the control group). Thus 105 patients were left for analysis, with 54 in the RIPC group and 51 in the control group (Figure 1) .
The study was approved by the regional ethical committee, and informed consent was procured. A computerized randomization table for the random allocation of patients was established. A secretary blinded to the randomization table assessed patient eligibility, and a study nurse, not involved in analyzing data, enrolled patients and assigned and performed the intervention. The cardiac surgeon and all care providers were blinded to treatment.
Remote Ischemic Preconditioning
In the intervention group, RIPC was performed by applying a blood pressure cuff (age-adjusted size) around the child's leg. The cuff was inflated to 40 mm Hg above the systolic pressure in 4 cycles of 5 minutes. Every cycle of ischemia was followed by 5 minutes of reperfusion. The first RIPC cycle started after anesthesia induction, when invasive arterial blood pressure monitoring was established. For reproducibility, RIPC was performed on the right leg with only a few exceptions, when that leg was used for invasive catheters. Time from the last RIPC cycle to initiation and weaning of ECC was recorded. An uninflated cuff was applied on the leg in the control group.
Patient Characteristics
We recorded the following patient characteristics in the 2 groups to check for potential confounders after randomization: demographic data, preoperative plasma creatinine (in micromoles per liter), estimated glomerular filtration rate 65 in boys at least 13 years old, and k ¼ 0.55 in girls at least 13 years old), preoperative renal insufficiency (incidence of plasma creatinine above the reference level corrected for age), the Risk Adjustment for Congenital Heart Surgery 1 (RACHS-1) score corresponding to each surgical procedure (score system 1-6, with the highest number indicating the highest complexity of procedure 17 ), preoperative hemoglobin, preoperative saturation, ECC time, circulatory arrest, nadir temperature at ECC, incidence of univentricular heart, incidence of chromosome abnormality and syndromes, and incidence of previous heart surgery (!1 surgical intervention). We also recorded the incidence of infections (defined as a combination of clinical suspicion and use of antibiotics preoperatively or extended treatment with antibiotics beyond the normal prophylactic treatment given for 48 hours or change from prophylactic cefuroxime to piperacillin sodium [INN piperacillin] and tazobactam), because infection has been shown to increase plasma neutrophil gelatinase-associated lipocalin (NGAL) independently of AKI. 18 The anesthetic drug regimen used was also registered (high-dose fentanyl, sevoflurane and fentanyl/propofol, or propofol and fentanyl), because several investigations have shown a preconditioning-like effect of volatile anesthetics. 19 
Renal End Points
Renal end points foremost included AKI (defined as fulfilling ! 1 of the RIFLE criteria 20 : R, risk, plasma creatinine times 1.5 or urinary output <0.5 mL/[kg $h] for 6 hours; I, injury, plasma creatinine times 2 or urinary output<0.5 mL/[kg $ h] for 12 hours; F, failure, plasma creatinine times 3 or plasma creatinine ! 350 mmoL/L in the setting of an acute increase of at least 44 mmoL/L or urinary output<0.3 mL/[kg $ h] for 24 hours or anuria for 12 hours; L, loss, need for dialysis for longer than 4 weeks; E, end-stage, need for dialysis for longer than 3 months), with patients categorized
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according to the RIFLE criteria met at the worst values for plasma creatinine or urinary output. Initiation of dialysis (treatment with peritoneal dialysis or hemodialysis initiated on the basis of fluid overload, metabolic acidosis, or hyperkalemia) was recorded. Plasma creatinine, eGFR, plasma cystatin C, plasma NGAL, urinary NGAL, ratio of urinary NGAL to urinary creatinine, and urinary output were also recorded. Creatinine levels were analyzed by dry-slide technology with the Vitros 5.1 system (Ortho-Clinical Diagnostics, Inc, Rochester, NY) for routine measurement.
Cystatin C levels were measured with the N Latex cystatin C assay on the Behring Nephelometer II (Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany). The samples were analyzed in duplicate, and all samples from each subject were analyzed in a single run. One technician performed all assays. The intra-assay coefficient of variation (CV) was 2.5%, and the interassay CV was 4.9%.
NGAL levels were measured in duplicate with a commercially available enzyme-linked immunosorbent assay kit (kit 036; BioPorto Diagnostics A/S, Gentofte, Denmark). The analyses were carried out as described in our previous study, in which we validated the NGAL enzyme-linked immunosorbent assay kit. 21 For plasma, the intra-assay CV was 1.7%, and the interassay CV was 8.1%. For urine, the intra-assay CV was 1.9%, and the interassay CV was 10.5%. Macroscopic hemolysis in plasma and hematuria were registered. Urinary NGAL was divided by urinary creatinine to correct for urine dilution.
Secondary End Points
Secondary end points were as follows: low blood pressure (incidence of postoperative arterial blood pressure below the age reference level), highest 
3 100] to calculate the IS 22 ), reoperation during hospital stay, stay in the intensive care unit (ICU), hospital stay (days from postoperative ICU arrival until discharge), and in-hospital death.
Preoperative plasma and urine samples were collected after the induction of anesthesia, except for plasma creatinine which was taken within 1 week before surgery. Postoperative samples were collected at ICU arrival, 4 hours after ICU arrival, and in the mornings on postoperative day (POD) 1, POD 2, and POD 3. Sample collection stopped before POD 3 if the invasive or bladder catheter was removed. The time point of collection was registered for more than 70% of samples, and we found no difference between the RIPC and the control groups (mean AE SD time in hours from ECC end to sample collection at any of the prespecified time points) as follows: arrival at ICU, RIPC ¼ 2. All samples were centrifuged at 3500 rpm for 10 minutes, and the supernatants were stored at À80 C until analysis. Data on urinary output, blood pressure, and IS (averaged hourly from arrival at ICU until POD 3) were obtained from the patient data management system (Picis Care Suite; Picis, Inc, Wakefield, Mass) at the ICU and were registered for the first postoperative day (from ICU arrival to 6:00 AM on POD1) and for PODs 1 through 3 (6:00 AM-6:00 AM). Data on reoperation during hospital stay, stay at the ICU, hospital stay, and in-hospital deaths were obtained from the medical records. 
Statistics
Data are displayed as mean AE SD or as median and interquartile range as appropriate. We used the Student t test or Mann-Whitney rank sum test as appropriate to compare continuous variables and the c 2 test or Fisher's Exact test to compare categoric variables. For measurements of every renal biomarker, eGFR, urinary output, preoperative hemoglobin, and ECC time, we transformed data to a logarithmic scale to fulfill the assumption about normality.
For every renal biomarker, eGFR, and urinary output, we used multivariate analyses of variance for repeated measurements to test for difference across time points between the RIPC and control group. The hypothesis of parallel curves was first tested with a likelihood ratio test; if this hypothesis could not be rejected, the hypothesis of equal curves was tested. If the hypothesis of equal curves could not be rejected, the hypothesis of differences between time points for the approximated common curve was tested. STATA/IC 11.1 was used for data analysis.
Recruitment rate was lower than anticipated, but no changes to methods had to be undertaken during the study. Funding agencies had no role in designing the study, interpreting the data, writing the report, or making the decision to submit the report for publication.
RESULTS
Patient characteristics were similar in the RIPC group and the control group (Table 1) . No unintended effects or harm of RIPC were detected.
Renal End Points
In the RIPC group, 27 (50%) had AKI develop, compared with 30 (59%) in the control group (P >.2; Table  2 ), which was also the result for the incidence of at least a 50% increase in plasma creatinine. AKI was diagnosed on the basis of an isolated creatinine increase in 81% of the children, whereas in 19% it was diagnosed on the basis of a combination of creatinine increase and associated oliguria. There was no difference in frequency of the type of AKI between the RIPC and control group (P >.2). After stratification of AKI according to the RIFLE criteria, the tendency toward a lower incidence of AKI in the RIPC group was limited to the mildest degrees of AKI, namely the R and I criteria, with the strongest tendency in the R criteria ( Table 2 ). The mean difference between preoperative eGFR and nadir postoperative eGFR in the RIPC group was 32% AE 3.2%; the difference was 35% AE 2.5% in the control group (P >.2). Dialysis was initiated in 7 patients in the RIPC group (13%) and in 5 patients in the control group (10%; P >.2; Table 2 ). There were no differences in the levels of the renal biomarkers with time between the RIPC group and the control group. In the 2 groups combined, renal biomarkers, eGFR, and urinary output all changed significantly with time ( Figure 2 ). Correcting urinary NGAL for urinary creatinine did not change this conclusion.
A separate analysis of children older than 6 months (RIPC, n ¼ 32; control, n ¼ 30) showed a difference in the incidence of AKI (41% in RIPC group and 67% in control group; P ¼ .04); however, this protective effect of RIPC was not reflected in any other of the renal end points or in any secondary end points (data not shown).
Secondary End Points
We found no difference in secondary end points between the RIPC group and the control group (Table 2) .
DISCUSSION
In this study, we found no evidence of kidney protection provided by RIPC in children undergoing operation for complex congenital heart disease. We found a tendency toward a lower incidence of AKI as defined by changes in plasma creatinine and urinary output (the RIFLE criteria), but this tendency was not supported by changes in more recently developed renal biomarkers.
In 2007, Ali and colleagues 13 showed a beneficial effect of RIPC on kidney function, performed as crossclamping of the iliac arteries, in patients undergoing surgery for abdominal aortic aneurysm; however, a recent, larger study by Rahman and associates 14 in patients undergoing coronary artery bypass grafting could not demonstrate any effect on kidney, heart, or lung function. Furthermore, Choi and coworkers 16 confirmed that RIPC could not protect kidney function in adults after complex valvular heart surgery. The reasons for these conflicting results could be related to the surgical procedure and thereby the degree of ischemia-reperfusion injury or to differences in RIPC techniques.
Cheung and associates 6 and Zhou and coworkers 8 found a beneficial effect of RIPC on heart and lung function in children undergoing operation for congenital heart disease. In our study, we found no effect of RIPC on the incidence of low blood pressure or IS. There are, however several differences between the study by Cheung and associates 6 and our own study that may explain this discrepancy. In Cheung and associates' study, 6 most of the children (84%) were in RACHS-1 category 2, compared with only 13% in this study. ECC time was also shorter in Cheung and associates' study 6 (mean ECC time, RIPC, 80 minutes, vs control, 88 minutes; compare with our study in Table 1 ), as was stay in the ICU (mean ICU stay, RIPC, 2.3 days, vs control, 1.7 days; compare with our study in Table 2 ). It therefore seems that morbidity in the study population of Cheung and associates 6 was lower than that in our study population, and thus RIPC may be less protective with greater complexity of heart disease. This may also be true for the study by Zhou and coworkers, 8 who only included ventricular septal defects (RACHS-1 category 2).
Another factor that may have influenced the outcome after RIPC is the interval between RIPC and initiation of ECC. RIPC was performed 5 to 10 minutes before initiation of bypass in the study by Cheung and associates 6 and 24 hours and 1 hour before surgery in the study by Zhou and coworkers. 8 According to the review by Kanoria and colleagues, 23 the first heart protective window of RIPC In-hospital death (no.) 1 (2%) 2( 4 %) .61
RIPC, Remote ischemic preconditioning; IQR, interquartile range. *Acute kidney injury was defined as fulfilling at least 1 of the RIFLE criteria: R, risk, plasma creatinine times 1.5 or urinary output less than 0.5 mL/(kg $ h) for 6 hours; I, injury, plasma creatinine times 2 or urinary output less than 0.5 mL/(kg $ h) for 12 hours; F, failure, plasma creatinine times 3 or plasma creatinine at least 350 mmoL/L in the setting of an acute increase of at least 44 mmoL/L or urinary output less than 0.3 mL/(kg $ h) for 24 hours or anuria for 12 hours; L, loss, need for dialysis for longer than 4 weeks; E, end-stage, need for dialysis for longer than 3 months. yLow blood pressure was defined as incidence of low blood pressure (below the age-reference level).
is within the first 4 hours and the second window after 24 hours as a result of protein-independent and proteindependent phases. The median time between RIPC and start of ECC in this study was 65 minutes, which represents the time between RIPC and the ischemic part of the ischemia-reperfusion injury. The median time between RIPC and completion of ECC was 187 minutes, which represents the time between RIPC and the reperfusion part of the ischemia-reperfusion injury (Table 1) . This means that even though timing of RIPC was different in these 3 studies, the ischemic part of the ischemia-reperfusion injury overall happened within the first window of RIPC protection for all studies. Children with prolonged preceding procedures or long ECC time, however, received their reperfusion injury outside the first window of RIPC, which may have reduced the effect of the first RIPC protective window in our study. Because the time between surgery and start of ECC was not given in the study by Zhou and coworkers, 8 it is unknown whether their patients fully benefited from the first protective window.
The cuff inflation pressure could also have influenced the effect of RIPC. Cheung and associates 6 used a pressure of 15 mm Hg above systolic pressure, and Zhou and coworkers 8 inflated the cuff to 240 mm Hg. We used a cuff inflation pressure of 40 mm Hg above systolic pressure, which is in between the 2 previous studies.
The lower incidence of AKI associated with RIPC in the children older than 6 months may indicate that a certain maturation of the kidneys is needed for a response to RIPC.
More subtle protection may have revealed itself in some of the new renal markers. There was no evidence of any difference, however, in the release of either cystatin C or NGAL. External factors known to influence the NGAL level in plasma include inflammation (cystic fibrosis 24 and COPD 25 ) and infections. 18 There was, however, no difference in the incidence of infection between the 2 groups. Only 1 patient was treated for asthma with glucocorticoid inhalation; otherwise, the children did not have any comorbidities. The inflammatory response after cardiac surgery is FIGURE 2. Measurements of plasma and urinary renal biomarkers, estimated glomerular filtration rate (eGFR), and urinary output with time in the remote ischemic preconditioning group and control group. Filled circles represent the remote ischemic preconditioning group; open circles represent the control group. Nc, Number of patients in the control group; Nr, number of patients in the RIPC group; ICU, intensive care unit; POD, postoperative day; NGAL, neutrophil gelatinase-associated lipocalin. Mean and SE are presented. There were no significant differences with time between the 2 groups in any of the renal end point measurements. Asterisk indicates P <.05 for the difference from the preoperative measurement in the combined group. related to the duration of ECC, which was comparable in the 2 groups.
Imprecision in the measurement of NGAL could have obscured a potential difference. We have previously shown that hemolysis increases NGAL measurements in plasma. 21 Patients with visible hemolysis and hematuria were equally distributed between the RIPC and the control group. Excluding these patients from the analysis did not reveal any beneficial effect of RIPC on plasma or urinary NGAL (data not shown). The mechanisms of ischemia-reperfusion injury and protection afforded by RIPC differ among organs, and the kidneys may have weaker protective responses than organs (such as the heart, lungs, and brain) that appear to receive clinically relevant protection from RIPC. Further mechanistic studies of renal ischemia-reperfusion injury are merited to guide clinical trials geared toward optimizing protective effects of pharmacologic or ischemic preconditioning. Referral for operation was population based, and the results therefore can be generalized to most surgical procedures for complex congenital heart disease.
Limitations
The study is undersized to detect less than a 30% reduction in AKI. The observed reduction in AKI of approximately 10% would have required 480 children in each group to show statistically significance. The relative low frequency of high RACHS-1 scores among our patients might have reduced the overall occurrence of AKI; however, AKI did develop in 59% of patients in the control group, which is in accordance with the assumption that we made in the power calculation.
Although we used more than 1 renal biomarker, the end points for renal function used in this study may still have been too insensitive and unspecific.
AKI developed during the first 24 hours, and renal function improved after this time. Within the first 24 hours, the number of missing values did not exceed 5%, and dropouts were only an issue after the second postoperative day. To compensate for missing data, we increased the total number of children above the estimated power calculation. We therefore consider the incomplete data set unlikely to have changed the overall findings in this study.
The optimal measure of renal function could be ethylenediaminetetraacetic acid clearance; however, performance of this test is complicated by the invasive nature of the technique.
The vast majority of the children were anesthetized with sevoflurane, equally distributed between the RIPC group and the control group. A preconditioning effect of sevoflurane thus may have provided a renal protection that could not be augmented by RIPC. The children in the study by Cheung and associates 6 were all anesthetized with sevoflurane, however, and those investigators found heart and lung RIPC protective effects.
CONCLUSIONS
In this randomized study of RIPC in children during surgery for complex congenital heart disease, we could not demonstrate any beneficial effect on the postoperative occurrence of AKI. Furthermore, we found no evidence that RIPC affected the plasma level of cystatin C or the release of NGAL in plasma and urine.
